Home/ Stocks/ FBIO

Fortress Biotech, Inc.

FBIO XNAS

$2.39 +0.09 (+3.78%) ▲ 15-min delayed

Open

$2.44

High

$2.44

Low

$2.36

Volume

97.3K

Market Cap

$79.39M

About Fortress Biotech, Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 78 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$63.26M	$-32,915,000	$-0.07
FY 2025	$63.26M	$-32,915,000	$-0.07
Q3 2025	$17.63M	$8.83M	$0.13
Q2 2025	$16.41M	$-11,654,000	$0.50

Related Market News

No specific coverage for FBIO yet. Check out our latest market news or earnings calendar.

Get FBIO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Fortress Biotech, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.